Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 8:52 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1369–1392 of 2,913 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Event Clear all

Conditions: Anaemia
Interventions: Daprodustat, Darbepoetin alfa, Placebo, Iron Therapy; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 3,872 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 161
States / cities: Andalusia, Alabama • Birmingham, Alabama • Huntsville, Alabama + 128 more

Conditions: Anesthesia, Propofol Adverse Reaction, Etomidate Adverse Reaction, Anesthesia Complication, Anesthesia; Adverse Effect, Anesthesia; Reaction
Interventions: Admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2), Admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7); Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Allogeneic Hematopoietic Stem Cell
Interventions: fecal microbiota transplantation (FMT), No fecal microbiota transplantation (FMT), routine management; Biological · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Colorectal Neoplasm
Interventions: DS-8273a + nivolumab; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Grand Rapids, Michigan • Houston, Texas + 1 more

Conditions: Systemic Lupus Erythematosus
Interventions: Zostavax vaccine; Drug
Lead sponsor: Oklahoma Medical Research Foundation; Other
Eligibility: 50 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Pregnancy, Sexually Transmitted Diseases
Interventions: SEI Classroom Curriculum, Control Classroom Curriculum, SEI Curriculum + 3 School Components, Control Curriculum + 1 School Component; Behavioral
Lead sponsor: Public Health Institute, California; Other
Eligibility: 13 Years to 16 Years
Enrollment: 1,909 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Acute Ischemic Stroke
Interventions: Penumbra System; Device
Lead sponsor: Penumbra Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Atherosclerosis
Interventions: Darapladib, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 15,828 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 155
States / cities: Birmingham, Alabama • Huntsville, Alabama • Anchorage, Alaska + 132 more

Conditions: Urinary Tract Infections
Interventions: Decision Aid-prediction model; Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: HIV/AIDS, Cocaine Use
Interventions: Group A_No feedback, Group B_Automated feedback, Group C_Automated feedback + Clinician feedback, Group D_Automated feedback + Social Network feedback; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Knee Injuries
Interventions: Biofeedback Knee Sleeve, Sham Biofeedback; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 12 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Anesthesia, Surgery, Critical Illness, Critical Incident
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: Up to 17 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Myocardial Injury
Interventions: ticagrelor, aspirin; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 40 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 24
States / cities: Mobile, Alabama • Little Rock, Arkansas • Jacksonville, Florida + 19 more

Conditions: Suicide, Attempted
Interventions: Attempted Suicide Short Intervention Program, Zero Suicide Usual Care; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 443 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 3
States / cities: Rochester, New York • Syracuse, New York

Conditions: Dementia, Mild Cognitive Impairment, Alzheimer Disease
Interventions: In-Home Technology System, Limited In-Home Technology; Device
Lead sponsor: University of California, Berkeley; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Anxiety, Depression
Interventions: Happy Older Latinos are Active, Fotonovela; Behavioral · Other
Lead sponsor: University of Miami; Other
Eligibility: 60 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Acute Coronary Syndrome
Interventions: Losmapimod 7.5 mg twice daily, Placebo twice daily, Standard therapy; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 35 Years and older
Enrollment: 3,503 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 91
States / cities: Huntsville, Alabama • Cottonwood, Arizona • Tucson, Arizona + 83 more

Conditions: Small Cell Lung Cancer
Interventions: ABBV-706, Atezolizumab, Etoposide, Carboplatin, Lurbinectedin; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 12
States / cities: New Haven, Connecticut • Gainesville, Florida • Ocala, Florida + 9 more

Conditions: Physical Activity
Interventions: Physical Activity Intervention, Wellness Contact Control; Behavioral
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Pregnancy Complications, Stress, Physiological, High Risk Pregnancy
Interventions: Writing exercises; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Post Traumatic Stress Disorder (PTSD), Addiction, Alcohol Abuse
Interventions: N-Acetylcysteine (NAC) Treatment, Cognitive Behavioral Therapy (CBT), Inactive Placebo Oral Capsule, Functional magnetic resonance imaging (fMRI), Proton magnetic resonance spectroscopy (MRS) Imaging; Drug · Behavioral · Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 70 Years
Enrollment: 182 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 2
States / cities: Charleston, South Carolina

Conditions: Mixed Hearing Loss, Single-Sided Deafness, Conductive Hearing Loss
Interventions: Osia 2 System; Device
Lead sponsor: Cochlear; Industry
Eligibility: 5 Years to 11 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 7
States / cities: Phoenix, Arizona • Palo Alto, California • San Diego, California + 4 more

Conditions: Elder Abuse, Self Neglect, Aging, Domestic Abuse
Interventions: Surveillance camera(s); Behavioral
Lead sponsor: Rutgers University; Other
Eligibility: 60 Years and older
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Healthy
Interventions: Emotion valence, Time, TMS Stimulation; Other · Device
Lead sponsor: University of California, Santa Barbara; Other
Eligibility: 18 Years to 45 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Santa Barbara, California

Search by objective public record fields.

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer

Zostavax in Systemic Lupus Erythematosus

Randomized Evaluation of a Multi-Component, Rights-Based Sexuality Education Initiative for High School Students

Imaging Guided Patient Selection for Interventional Revascularization Therapy

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting

Project SMART Automated Pillbox Study

AI Driven Biofeedback Wearable

A Review of "Anesthesia Stat!" in the Pediatric Operating Room

Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery

Study About Treatment After a Suicide Attempt

In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Rural Homes

Exercise to Prevent Depression and Anxiety in Older Hispanics

A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)

A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

Increasing Physical Activity in Latino Men

Therapeutic Writing to Reduce Stress

Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)

Osia 2 Pediatric Expansion Study

Use Surveillance Technology to Reduce Elder Abuse Recidivism

LPFC Organization in Emotion-Duration Difference Estimation